Jeremy Gurewitz is CEO and Co-Founder of Solace Health, a digital healthcare advocacy platform that connects patients with expert advocates to navigate the complex U.S. healthcare system. He founded the company with CPO Sara Sargent in 2022 after watching his mother, an accomplished radiologist, struggle to navigate her own pancreatic cancer diagnosis.

Jeremy holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania. He served as VP of Marketing at Literati, VP of Growth at Imperfect Foods, and held growth leadership roles at Man Crates.

Jeremy began his career as an Associate Portfolio Manager in Quantitative Equity at Lord Abbett & Co. LLC from 2012 to 2016. He is regularly asked to speak about growth, acquisition, and retention at conferences.

Solace raised a $130M Series C led by IVP in February 2026, reaching a $1 billion valuation. The company serves more than 20,000 patients monthly and achieved 10x year-over-year growth.

Solace connects patients with over 2,000 trained advocates, often nurses, to manage logistics, appointments, and insurance hurdles. The platform is covered by Medicare and major Medicare Advantage insurers across all 50 U.S. states.